Yansha Hao
YOU?
Author Swipe
View article: Corrigendum to “Preclinical evaluation of the safety and effectiveness of a new bioartificial cornea” [Bioact. Mater. 2023 (8) 29 265–278]
Corrigendum to “Preclinical evaluation of the safety and effectiveness of a new bioartificial cornea” [Bioact. Mater. 2023 (8) 29 265–278] Open
[This corrects the article DOI: 10.1016/j.bioactmat.2023.07.005.].
View article: Cardiac Organoid Model Inspired Micro‐Robot Smart Patch to Treat Myocardial Infarction
Cardiac Organoid Model Inspired Micro‐Robot Smart Patch to Treat Myocardial Infarction Open
Post‐myocardial infarction (MI), the rapid decrease in pH triggers myocardial cell acidosis, which compromises the therapeutic efficacy of exosomes in MI. The groundbreaking research in the human cardiac organoid MI model suggests that exo…
View article: Construction of millimeter-scale vascularized engineered myocardial tissue using a mixed gel
Construction of millimeter-scale vascularized engineered myocardial tissue using a mixed gel Open
Engineering myocardium has shown great clinal potential for repairing permanent myocardial injury. However, the lack of perfusing blood vessels and difficulties in preparing a thick-engineered myocardium result in its limited clinical use.…
View article: Preclinical evaluation of the safety and effectiveness of a new bioartificial cornea
Preclinical evaluation of the safety and effectiveness of a new bioartificial cornea Open
Cross-linking agents are frequently used to restore corneal properties after decellularization, and it is especially important to select an appropriate method to avoid excessive cross-linking. In addition, how to promote wound healing and …